Cheng Teng Yeam

Cheng Teng Yeam

Auto-generated profile, based on publicly available information

Cheng Teng Yeam

Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2018 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
CYC. T. Yeam
C. T. Yeam
SCS. Chia
S. Chia
HTH. C. C. Tan
H. C. C. Tan
YKY. H. Kwan
Y. H. Kwan
WFW. Fong
W. Fong
JSJun Jie Benjamin Seng
Jun Jie Benjamin Seng

1 November 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
LLLian Leng LOW
Lian Leng LOW
YKYu Heng Kwan
Yu Heng Kwan
MKMichelle Shi Min Ko
Michelle Shi Min Ko
CYCheng Teng Yeam
Cheng Teng Yeam
VLVivian Shu Yi Lee
Vivian Shu Yi Lee
JTJulian Thumboo
Julian Thumboo
With the global challenge of an aging population and the increasing prevalence of multiple chronic diseases,1 a paradigm shift by governments and health care systems is essential in the management of limited resources and increasing medical expenditures. For people with multimorbidity, commonly defined as the same individual concurrently having 2 or more chronic conditions, the single-disease approach in health care delivery is often inefficient and duplicative.2 Therefore, this framework will have to evolve to become broader, more integrated, and with better coordination to accommodate patients’ varied clinical needs. The prevalence patterns of multimorbidity are associated with sociodemographic factors such as age3 and sex,4 ranging from 50% to 98% of people older than 65 years in different studies.5-7 Multimorbidity is also significantly associated with decreased functional status,8 reduced quality of life,4 greater use of health care resources,2,3 and high mortality rates.9

31 March 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
JSJun Jie Benjamin Seng
Jun Jie Benjamin Seng
JTJia Ying Tan
Jia Ying Tan
CYCheng Teng Yeam
Cheng Teng Yeam
HHHtay Htay
Htay Htay
WFWai Yin Marjorie Foo
Wai Yin Marjorie Foo

4 August 2020 in Drugs
Verified
Journal Article
Open access
PDF file
Giustino VarrassiGiustino Varrassi
Giustino Varrassi
CYCheng Teng Yeam
Cheng Teng Yeam
MRMartina Rekatsina
Martina Rekatsina
JPJoseph V. Pergolizzi
Joseph V. Pergolizzi
PZPanagiotis Zis
Panagiotis Zis
APAntonella Paladini
Antonella Paladini
Pain management in both outpatient and inpatient settings demands a multidisciplinary approach entailing medical, physical and psychological therapies. Among these, multimodal analgesic regimens stand out as a promising treatment options. Cyclo-oxygenase (COX) inhibitor/opioid receptor agonist combinations hold great potential as effective pillars in the multimodal pain management by providing adequate analgesia with fewer safety risks due to COX inhibitors’ opioid-sparing effect. Thus, these combinations, either freely or in fixed-dose formulation, offer a feasible option for the prescribing clinicians who seek to maximise therapeutic effect while simultaneously minimise adverse effects. The selection of the appropriate non-steroidal anti-inflammatory drug (NSAID) and opioid agent at optimal doses is essential. It should be tailored to the patients’ analgesic necessities, and his/her gastrointestinal and cardiovascular risk, and potential concurrent aspirin use. Moreover, it should allow for addiction risk and the potential opioid-induced bowel dysfunction and constipation. To ensure an optimal match between the characteristics of the patient and the properties of the chosen medication, and to guide adequate and well-tolerated treatment decisions, it is of paramount importance to expand clinicians’ knowledge of the currently available COX inhibitor/opioid receptor agonist combinations. This invited narrative review deals with the literature evidence covering the components of multimodal opioid-sparing analgesic regimens. Also, it provides insights into the clinically relevant choice criteria to ensure a patient-tailored analgesia.

25 April 2020 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
Joseph pergolizziJoseph pergolizzi
Joseph pergolizzi
PMPeter Magnusson
Peter Magnusson
MLMarianna Leopoulou
Marianna Leopoulou
FBFrank Breve
Frank Breve
APAntonella Paladini
Antonella Paladini
Giustino VarrassiGiustino Varrassi
Giustino Varrassi
The emergence of a novel coronavirus and coronavirus disease 2019 (COVID-19) represents a challenge to global healthcare. In the past 20 years, this is the ...

11 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
JSJun Jie Benjamin Seng
Jun Jie Benjamin Seng
CYCheng Teng Yeam
Cheng Teng Yeam
CHCaleb Weihao Huang
Caleb Weihao Huang
NTNgiap Chuan Tan
Ngiap Chuan Tan
LLLian Leng LOW
Lian Leng LOW
Background: Health literacy plays an essential role in one’s ability to acquire and understand critical medical information in the COVID-19 infodemic and other pandemics. Purpose: To summarize the assessment, levels and determinants of pandemic related health literacy and its associated clinical outcomes. Data sources: Medline®, Embase®, PsychINFO®, CINAHL®, arXiv, bioRxiv, medRxiv, and Social Science Research Network. The start date was unrestricted and current as of 22 April 2020. Study selection: Studies which evaluated health literacy related to novel coronavirus disease 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS) or Middle East Respiratory Syndrome (MERS) Data extraction: Data on the characteristics of study designs, instruments, participants and level of health literacy were collected. Items used in instruments were grouped under the themes of knowledge, attitudes and practices. Determinants of health literacy were grouped into five domains (socio-demographic, medical, psychological/psychiatric, health systems related and others). Data synthesis: Of 2,065 articles screened, 70 articles were included. 21, 17 and 32 studies evaluated health literacy related to COVID-19, SARS and MERS, respectively. The rates of low pandemic health literacy ranged from 4.3 to 57.9% among medical-related populations and 4.0% to 82.5% among non-medical populations. Knowledge about symptoms and transmission of infection; worry about infection and, practices related to mask usage and hand hygiene was most frequently evaluated. Socio-demographic determinants of health literacy were most studied, where higher education level, older age and female gender were associated with better health literacy. No studies evaluated outcomes associated with health literacy. Limitations: Non-English articles were excluded. Conclusion: The level of pandemic related health literacy is sub-optimal. Healthcare administrators need to be aware of health literacy determinants when formulating policies in pandemics.